Literature DB >> 26788171

Chondroblastic osteosarcoma secondary to fibrosarcoma: A case report and literature review.

Yi-Fei Zheng1, Jun Lin1, Hui-Lin Yang1.   

Abstract

Osteosarcoma, which is most common in non-blood systemic tumors, accounts for 20% of primary bone malignancies. Primary osteosarcoma usually occurs in young individuals aged 10-20 years, while secondary osteosarcoma is more common in the elderly. It had been reported that secondary osteosarcoma may be associated with osteofibrous dysplasia, bone infarction, chondrosarcoma or osteogenesis imperfecta. However, osteosarcoma secondary to fibrosarcoma has rarely been reported. The current study presents the rare case of a female with chondroblastic osteosarcoma secondary to fibrosarcoma. The patient was relatively young and suffered from more than one type of cancer. The course of the disease lasted for >20 years. This case study provides general knowledge of osteosarcoma, and discusses its clinical presentation, diagnosis, treatment and prognosis.

Entities:  

Keywords:  fibrosarcoma; osteosarcoma; secondary

Year:  2015        PMID: 26788171      PMCID: PMC4665868          DOI: 10.3892/ol.2015.3792

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

1.  The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.

Authors:  Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayhan Ozcan; Seref Komurcu; Bekir Ozturk; Bulent Celasun; Selim Kilic; Okan Kuzhan
Journal:  Cancer       Date:  2005-09-01       Impact factor: 6.860

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 3.  Osteosarcoma: review of the past, impact on the future. The American experience.

Authors:  Norman Jaffe
Journal:  Cancer Treat Res       Date:  2009

4.  p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.

Authors:  Minoru Nakase; Madoka Inui; Kenya Okumura; Takahiko Kamei; Shinnosuke Nakamura; Toshiro Tagawa
Journal:  Mol Cancer Ther       Date:  2005-04       Impact factor: 6.261

Review 5.  High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.

Authors:  Antonio Briccoli; Michele Rocca; Mariacristina Salone; Gaetano Antonio Guzzardella; Alba Balladelli; Gaetano Bacci
Journal:  Surg Oncol       Date:  2009-06-09       Impact factor: 3.279

6.  Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.

Authors:  Matthew T Harting; Kevin P Lally; Richard J Andrassy; Ara A Vaporciyan; Charles S Cox; Andrea Hayes-Jordan; Martin L Blakely
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-27       Impact factor: 4.553

7.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Authors:  Allen M Goorin; Douglas J Schwartzentruber; Meenakshi Devidas; Mark C Gebhardt; Alberto G Ayala; Michael B Harris; Lee J Helman; Holcombe E Grier; Michael P Link
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

8.  Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

Authors:  S Smeland; C Müller; T A Alvegard; T Wiklund; T Wiebe; O Björk; A E Stenwig; H Willén; T Holmström; G Follerås; O Brosjö; A Kivioja; K Jonsson; O Monge; G Saeter
Journal:  Eur J Cancer       Date:  2003-03       Impact factor: 9.162

Review 9.  Prognostic factors in osteosarcoma: a critical review.

Authors:  A M Davis; R S Bell; P J Goodwin
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

10.  Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.

Authors:  Timothy A Damron; William G Ward; Andrew Stewart
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

View more
  3 in total

1.  Prognostic factors to survival of patients with chondroblastic osteosarcoma.

Authors:  Hui-Hui Sun; Xiang-Yang Chen; Jia-Qu Cui; Zhao-Ming Zhou; Kai-Jin Guo
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

2.  Seeing the Invisible: The Value of Bone Scan to Distinguish Chondroblastic Osteosarcoma From Prosthesis Loosening.

Authors:  Tzyy-Ling Chuang; Yu-Ruei Chen; Yuh-Feng Wang
Journal:  Clin Nucl Med       Date:  2022-02-01       Impact factor: 7.794

3.  Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.

Authors:  Fengsong Liu; Kai Wang; Liang Zhang; Ya-Lin Yang
Journal:  Oncol Lett       Date:  2018-08-06       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.